Literature DB >> 28620095

Responses to Cytokines and Interferons that Depend upon JAKs and STATs.

George R Stark1, HyeonJoo Cheon1, Yuxin Wang1.   

Abstract

Many cytokines and all interferons activate members of a small family of kinases (the Janus kinases [JAKs]) and a slightly larger family of transcription factors (the signal transducers and activators of transcription [STATs]), which are essential components of pathways that induce the expression of specific sets of genes in susceptible cells. JAK-STAT pathways are required for many innate and acquired immune responses, and the activities of these pathways must be finely regulated to avoid major immune dysfunctions. Regulation is achieved through mechanisms that include the activation or induction of potent negative regulatory proteins, posttranslational modification of the STATs, and other modulatory effects that are cell-type specific. Mutations of JAKs and STATs can result in gains or losses of function and can predispose affected individuals to autoimmune disease, susceptibility to a variety of infections, or cancer. Here we review recent developments in the biochemistry, genetics, and biology of JAKs and STATs.
Copyright © 2018 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28620095      PMCID: PMC5749152          DOI: 10.1101/cshperspect.a028555

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   9.708


  132 in total

Review 1.  Transcription factor activity of STAT proteins: structural requirements and regulation by phosphorylation and interacting proteins.

Authors:  T Decker; P Kovarik
Journal:  Cell Mol Life Sci       Date:  1999-09       Impact factor: 9.261

2.  Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation.

Authors:  Z Wen; Z Zhong; J E Darnell
Journal:  Cell       Date:  1995-07-28       Impact factor: 41.582

3.  Observation of unphosphorylated STAT3 core protein binding to target dsDNA by PEMSA and X-ray crystallography.

Authors:  Edwin Nkansah; Rahi Shah; Gavin W Collie; Gary N Parkinson; Jonathan Palmer; Khondaker M Rahman; Tam T Bui; Alex F Drake; Jarmila Husby; Stephen Neidle; Giovanna Zinzalla; David E Thurston; Andrew F Wilderspin
Journal:  FEBS Lett       Date:  2013-02-19       Impact factor: 4.124

4.  Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis.

Authors:  Elizabeth P Sampaio; Amy P Hsu; Joseph Pechacek; Hannelore I Bax; Dalton L Dias; Michelle L Paulson; Prabha Chandrasekaran; Lindsey B Rosen; Daniel S Carvalho; Li Ding; Donald C Vinh; Sarah K Browne; Shrimati Datta; Joshua D Milner; Douglas B Kuhns; Debra A Long Priel; Mohammed A Sadat; Michael Shiloh; Brendan De Marco; Michael Alvares; Jason W Gillman; Vivek Ramarathnam; Maite de la Morena; Liliana Bezrodnik; Ileana Moreira; Gulbu Uzel; Daniel Johnson; Christine Spalding; Christa S Zerbe; Henry Wiley; David E Greenberg; Susan E Hoover; Sergio D Rosenzweig; John N Galgiani; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2013-03-28       Impact factor: 10.793

5.  Structure of the unphosphorylated STAT5a dimer.

Authors:  Dante Neculai; Ana Mirela Neculai; Sophie Verrier; Kenneth Straub; Klaus Klumpp; Edith Pfitzner; Stefan Becker
Journal:  J Biol Chem       Date:  2005-09-28       Impact factor: 5.157

6.  Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer.

Authors:  X Cui; L Zhang; J Luo; A Rajasekaran; S Hazra; N Cacalano; S M Dubinett
Journal:  Oncogene       Date:  2007-01-22       Impact factor: 9.867

7.  Drosophila STAT is required for directly maintaining HP1 localization and heterochromatin stability.

Authors:  Song Shi; Kimberly Larson; Dongdong Guo; Su Jun Lim; Pranabananda Dutta; Shian-Jang Yan; Willis X Li
Journal:  Nat Cell Biol       Date:  2008-03-16       Impact factor: 28.824

8.  Alternative activation of STAT1 and STAT3 in response to interferon-gamma.

Authors:  Yulan Qing; George R Stark
Journal:  J Biol Chem       Date:  2004-07-27       Impact factor: 5.157

9.  STAT5a activation mediates the epithelial to mesenchymal transition induced by oncogenic RhoA.

Authors:  Salvador Aznar Benitah; Pilar F Valerón; Hallgeir Rui; Juan Carlos Lacal
Journal:  Mol Biol Cell       Date:  2003-01       Impact factor: 4.138

10.  SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer.

Authors:  Z Zhou; M Wang; J Li; M Xiao; Y E Chin; J Cheng; E T H Yeh; J Yang; J Yi
Journal:  Oncogene       Date:  2016-05-16       Impact factor: 9.867

View more
  22 in total

Review 1.  Janus kinases to jakinibs: from basic insights to clinical practice.

Authors:  Massimo Gadina; Mimi T Le; Daniella M Schwartz; Olli Silvennoinen; Shingo Nakayamada; Kunihiro Yamaoka; John J O'Shea
Journal:  Rheumatology (Oxford)       Date:  2019-02-01       Impact factor: 7.580

Review 2.  Interleukin-6 Family Cytokines.

Authors:  Stefan Rose-John
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-02-01       Impact factor: 10.005

3.  The regulatory proteins DSCR6 and Ezh2 oppositely regulate Stat3 transcriptional activity in mesoderm patterning during Xenopus development.

Authors:  Mafalda Loreti; De-Li Shi; Clémence Carron
Journal:  J Biol Chem       Date:  2020-01-29       Impact factor: 5.157

4.  Anti-IL-23 exerted protective effects on cerebral ischemia-reperfusion injury through JAK2/STAT3 signaling pathway.

Authors:  Lichao Fan; Lichun Zhou
Journal:  Mol Biol Rep       Date:  2021-04-26       Impact factor: 2.316

Review 5.  Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology.

Authors:  Carlota Recio; Borja Guerra; Miguel Guerra-Rodríguez; Haidée Aranda-Tavío; Patricia Martín-Rodríguez; Mercedes de Mirecki-Garrido; Yeray Brito-Casillas; José M García-Castellano; Ana Estévez-Braun; Leandro Fernández-Pérez
Journal:  Oncogene       Date:  2019-02-19       Impact factor: 9.867

6.  Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization.

Authors:  Qi Zhang; Bingqiu Xiu; Liyi Zhang; Ming Chen; Weiru Chi; Lun Li; Rong Guo; Jingyan Xue; Benlong Yang; Xiaoyan Huang; Zhi-Ming Shao; Shenglin Huang; Yayun Chi; Jiong Wu
Journal:  J Immunother Cancer       Date:  2022-10       Impact factor: 12.469

7.  Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency.

Authors:  Paul Bastard; Jeremy Manry; Jie Chen; Jérémie Rosain; Yoann Seeleuthner; Omar AbuZaitun; Lazaro Lorenzo; Taushif Khan; Mary Hasek; Nicholas Hernandez; Benedetta Bigio; Peng Zhang; Romain Lévy; Shai Shrot; Eduardo J Garcia Reino; Yoon-Seung Lee; Soraya Boucherit; Mélodie Aubart; Rik Gijsbers; Vivien Béziat; Zhi Li; Sandra Pellegrini; Flore Rozenberg; Nico Marr; Isabelle Meyts; Bertrand Boisson; Aurélie Cobat; Jacinta Bustamante; Qian Zhang; Emmanuelle Jouangy; Laurent Abel; Raz Somech; Jean-Laurent Casanova; Shen-Ying Zhang
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

8.  Slfn2 Regulates Type I Interferon Responses by Modulating the NF-κB Pathway.

Authors:  Mariafausta Fischietti; Ahmet D Arslan; Antonella Sassano; Diana Saleiro; Beata Majchrzak-Kita; Kazumi Ebine; Hidayatullah G Munshi; Eleanor N Fish; Leonidas C Platanias
Journal:  Mol Cell Biol       Date:  2018-07-30       Impact factor: 4.272

Review 9.  The 'cytokine storm': molecular mechanisms and therapeutic prospects.

Authors:  Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Trends Immunol       Date:  2021-07-01       Impact factor: 19.709

Review 10.  Molecular cross-talk of IL-6 in tumors and new progress in combined therapy.

Authors:  Zuoqing Song; Dian Ren; Xiaohong Xu; Yuxin Wang
Journal:  Thorac Cancer       Date:  2018-03-30       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.